EuBiologics Co., Ltd. (KOSDAQ:206650)
South Korea · Delayed Price · Currency is KRW 12,710
+20 (0.16%)
Aug 14, 2025, 3:30 PM KST
EuBiologics Market Cap
EuBiologics has a market cap or net worth of 465.49 billion as of August 14, 2025. Its market cap has increased by 17.92% in one year.
Market Cap
465.49B
Enterprise Value
462.23B
Revenue
96.04B
Ranking
n/a
PE Ratio
18.72
Stock Price
12,710.00
Market Cap Chart
Since January 24, 2017, EuBiologics's market cap has increased from 122.86B to 465.49B, an increase of 278.89%. That is a compound annual growth rate of 16.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 464.76B | 4.70% |
| Dec 30, 2024 | 443.89B | 6.16% |
| Dec 28, 2023 | 418.14B | 28.91% |
| Dec 29, 2022 | 324.36B | -74.49% |
| Dec 30, 2021 | 1,271.41B | 93.99% |
| Dec 30, 2020 | 655.40B | 209.65% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 24, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.67T |
| Celltrion | 38.01T |
| ALTEOGEN | 23.22T |
| Yuhan | 8,309.02B |
| SK Biopharmaceuticals | 7,737.35B |
| Peptron | 7,117.34B |
| PharmaResearch | 6,950.67B |
| LigaChem Biosciences | 5,361.69B |